패혈증의 치료 동향
Current Insights into Sepsis Treatments
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Sepsis is a common illness of intensive care unit patients that carries high morbidity and mortality, and increases hospital costs. Although mortality from sepsis remains high when compared with other critical illnesses, it has declined over the last few decades due to several adjunctive therapies and focused care programs or guidelines. In 2004, an international guideline was published that the bedside clinician could use to improve the outcomes in severe cases of sepsis and septic shock. Several landmark studies recently demonstrated that therapeutic strategies may substantially reduce mortality. The Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock: 2008 was updated using a new evidence-based methodology system for assessing the quality of evidence and the strengths of recommendations. Evidence-based recommendations regarding the acute management of sepsis and septic shock are the first step toward improving the outcomes of critically ill patients. This article discusses the guidelines and current insights into sepsis treatment.
Abstract
Sepsis is a common illness of intensive care unit patients that carries high morbidity and mortality, and increases hospital costs. Although mortality from sepsis remains high when compared with other critical illnesses, it has declined over the last few decades due to several adjunctive therapies and focused care programs or guidelines. In 2004, an international guideline was published that the bedside clinician could use to improve the outcomes in severe cases of sepsis and septic shock. Several landmark studies recently demonstrated that therapeutic strategies may substantially reduce mortality. The Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock: 2008 was updated using a new evidence-based methodology system for assessing the quality of evidence and the strengths of recommendations. Evidence-based recommendations regarding the acute management of sepsis and septic shock are the first step toward improving the outcomes of critically ill patients. This article discusses the guidelines and current insights into sepsis treatment.
참고문헌 (33)
- Watson RS, "The epidemiology of severe sepsis in children in the United States", Am J Respir Crit Care Med, 167, pp.695~701 (2003)
- Woodward B, "Safety of drotrecogin alfa (activated) in severe sepsis: data from adult clinical trials and observational studies", J Crit Care, 24, pp.595~602 (2009)
- Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis", Chest, 101, pp.1644~1655 (1992), The ACCP[DOI]
- Dellinger RP, "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008", Crit Care Med, 36, pp.296~327 (2008)
- van Ruler O, "Has mortality from sepsis improved and what to expect from new treatment modalities: review of current insights", Surg Infect (Larchmt), 10, pp.339~348 (2009)
- Martin GS, "The epidemiology of sepsis in the United States from 1979 through 2000", N Engl J Med, 348, pp.1546~1554 (2003)
- Clancy R, "Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils", J Leukoc Biol, 58, pp.196~202 (1995)
- Panas D, "Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism", Am J Physiol, 275, pp.H 1016~1023 (1998)
- Houck PM, "Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia", Arch Intern Med, 164, pp.637~644 (2004)
- Ibrahim EH, "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting", Chest, 118, pp.146~155 (2000)
- Esteban A, "Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group", Am J Respir Crit Care Med, 159, pp.512~518 (1999)
- Brower RG, "Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome", N Engl J Med, 351, pp.327~336 (2004)
- Cooper MS, "Corticosteroid insufficiency in acutely ill patients", N Engl J Med, 348, pp.727~734 (2003)
- Finlay WE, "Serum cortisol levels in severely stressed patients", Lancet, 1, pp.1414~1415 (1982)
- Rothwell PM, "Cortisol response to corticotropin and survival in septic shock", Lancet, 337, pp.582~583 (1991)
- Cohen J, "Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population", Intensive Care Med, 32, pp.1901~1905 (2006)
- Venkatesh B, "Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study", Anaesth Intensive Care, 33, pp.201~209 (2005)
- Mason PE, "CORTICUS: the end of unconditional love for steroid use?", Crit Care, 13, pp.309~ (2009)
- Sprung CL, "Hydrocortisone therapy for patients with septic shock", N Engl J Med, 358, pp.111~124 (2008)
- Annane D, "Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review", JAMA, 301, pp.2362~2375 (2009)
- Griesdale DE, "Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data", CMAJ, 180, pp.821~827 (2009)
- Frankenfield DC, "Correlation between measured energy expenditure and clinically obtained variables in trauma and sepsis patients", JPEN J Parenter Enteral Nutr, 18, pp.398~403 (1994)
- NICE-SUGAR Study Investigators, "Intensive versus conventional glucose control in critically ill patients", N Engl J Med, 360, pp.1283~1297 (2009)
- van den Berghe G, "Intensive insulin therapy in the critically ill patients", N Engl J Med, 345, pp.1359~1367 (2001)
- Van den Berghe G, "Intensive insulin therapy in the medical ICU", N Engl J Med, 354, pp.449~461 (2006)
- Brunkhorst FM, "Intensive insulin therapy and pentastarch resuscitation in severe sepsis", N Engl J Med, 358, pp.125~139 (2008)
- Krinsley JS, "Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients", Mayo Clin Proc, 78, pp.1471~1478 (2003)
- Inzucchi SE, "Clinical practice. Management of hyperglycemia in the hospital setting", N Engl J Med, 355, pp.1903~1911 (2006)
- Bernard GR, "Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis", Crit Care Med, 29, pp.2051~2059 (2001)
- Abraham E, "Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death", N Engl J Med, 353, pp.1332~1341 (2005)
- Brosnahan AJ, "Cytolysins augment superantigen penetration of stratified mucosa", J Immunol, 182, pp.2364~2373 (2009)
- Chau TA, "Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome", Nat Med, 15, pp.641~648 (2009)
- Sprong T, "Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock", Clin Infect Dis, 49, pp.1380~1386 (2009)